Latest News for: myeloid

Edit

Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, ...

Nasdaq Globe Newswire 20 Mar 2025
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline ... .
Edit

How does Acute Myeloid Leukemia affect mental health and emotional well-being in patients?

The Times of India 20 Mar 2025
It often starts with something small ... Before you can catch your breath, you hear the words, “You have blood cancer, a particularly aggressive kind called Acute Myeloid Leukemia.” In an instant, everything changes.
Edit

Sanofi to acquire Dren Bio's bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline (Form 6-K) (Sanofi SA)

Public Technologies 20 Mar 2025
Sanofi to acquire Dren Bio's bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline • ... myeloid cells to induce deep B-cell depletion via targeted phagocytosis.
Edit

Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline (Sanofi SA)

Public Technologies 20 Mar 2025
DR-0201 is a potential first-in-class CD20-directed bispecific antibody that targets and engages specific tissue-resident and trafficking myeloid cells to induce deep B-cell depletion via targeted phagocytosis.
Edit

Actinium Pharmaceuticals Announces Publication of Actimab-A + CLAG-M Trial Results in Patients with Relapsed or Refractory Acute Myeloid Leukemia in the Peer-Reviewed Journal Leukemia

PR Newswire 17 Mar 2025
Over the course of 2025, we expect to generate additional clinical data further supporting Actimab-A's mutation agnostic, backbone therapy potential for radiation sensitive myeloid malignancies.".
Edit

Chronic Myeloid Leukemia Market Expected to Experience Major Growth by 2032, According to DelveInsight | ...

GetNews 07 Mar 2025
The Key Chronic Myeloid Leukemia Companies in the market include - Enliven Therapeutics, Terns Pharmaceuticals, Ascentage Pharma, Novartis, M.D ... Some of the key facts of the Chronic Myeloid Leukemia Market Report. ... Chronic Myeloid Leukemia Overview.
Edit

Acute Myeloid Leukemia Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 06 Mar 2025
It covers the Acute Myeloid Leukemia pipeline drug profiles, including Acute Myeloid Leukemia clinical trials and nonclinical stage products.
Edit

COMBINATION OF APPROVED DRUGS OFFERS NEW STRATEGIES FOR ACUTE MYELOID LEUKEMIA

Pharmiweb 05 Mar 2025
KL Krems study shows synergistic effect ... Acute myeloid leukemia (AML) is an aggressive form of blood cancer in which immature white blood cells proliferate in the bone marrow and interfere with normal blood cell formation ... Dr ... TINY SHIFTS. BIG IMPACT ... .
  • 1
×